Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
British Journal of Pharmacology|March 29, 2022
Niclosamide-A promising treatment for COVID-19Shivani Singh, Anne Weiss, James Goodman, et al.
The British Journal of Cardiology|March 18, 2026
Long-term blood pressure variability: an emerging cardiovascular risk factorAllis Lai, Lawrence Lam, Akshita Raminemi, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|September 4, 2018
A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidoneMichael A Weber, Peter Sever, Attila Juhasz, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 8, 2023
Amlodipine in the current management of hypertensionJi-Guang Wang, Biff F Palmer, Katherine Vogel Anderson, et al.
Journal of Hypertension|March 14, 2025
Blood pressure variability: a reviewSpoorthy Kulkarni, Gianfranco Parati, Sripal Bangalore, et al.
Journal of Human Hypertension|December 9, 2024
Investigation and management of resistant hypertension: British and Irish Hypertension Society position statementLuca Faconti, Jacob George, Sarah Partridge, et al.
Trials|July 10, 2020
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trialSpoorthy Kulkarni, Marie Fisk, Michalis Kostapanos, et al.
Journal of Hypertension|November 6, 2025
The impact of blood pressure variability on cardiovascular and renal outcomes in patients with and without diabetes: insights from the Anglo-Scandinavian Cardiac Outcomes TrialSomayeh Rostamian, Amit Kaura, Cono Ariti, et al.
Trials|August 2, 2020
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trialIng Ni Lu, Spoorthy Kulkarni, Marie Fisk, et al.
Lancet (London, England)|May 7, 2017
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phaseAjay Gupta, David Thompson, Andrew Whitehouse, et al.
Pageof 11